These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 1609038

  • 1. A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency.
    Jenkins SW, Warfield NA, Blaine JD, Cornish J, Ling W, Rosen MI, Urschel H, Wesson D, Ziedonis D.
    Psychopharmacol Bull; 1992; 28(1):21-6. PubMed ID: 1609038
    [Abstract] [Full Text] [Related]

  • 2. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 3. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
    Feiger AD.
    Psychopharmacol Bull; 1996 Aug; 32(4):659-65. PubMed ID: 8993088
    [Abstract] [Full Text] [Related]

  • 4. Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.
    Feiger AD, Heiser JF, Shrivastava RK, Weiss KJ, Smith WT, Sitsen JM, Gibertini M.
    J Clin Psychiatry; 2003 Mar; 64(3):243-9. PubMed ID: 12716264
    [Abstract] [Full Text] [Related]

  • 5. Sustained efficacy of gepirone-IR in major depressive disorder: a double-blind placebo substitution trial.
    Amsterdam JD, Brunswick DJ, Gibertini M.
    J Psychiatr Res; 2004 Mar; 38(3):259-65. PubMed ID: 15003431
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 7. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
    McDowell D, Nunes EV, Seracini AM, Rothenberg J, Vosburg SK, Ma GJ, Petkova E.
    Drug Alcohol Depend; 2005 Nov 01; 80(2):209-21. PubMed ID: 15913920
    [Abstract] [Full Text] [Related]

  • 8. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP, Gardner EA, Johnston JA, Batey SR, Khayrallah MA, Ascher JA, Lineberry CG.
    J Clin Psychiatry; 1991 Aug 01; 52(8):329-35. PubMed ID: 1907963
    [Abstract] [Full Text] [Related]

  • 9. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD.
    J Clin Psychiatry; 1995 Nov 01; 56(11):519-25. PubMed ID: 7592505
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence.
    Winhusen T, Somoza E, Sarid-Segal O, Goldsmith RJ, Harrer JM, Coleman FS, Kahn R, Osman S, Mezinskis J, Li SH, Lewis D, Afshar M, Ciraulo DA, Horn P, Montgomery MA, Elkashef A.
    Drug Alcohol Depend; 2007 Dec 01; 91(2-3):205-12. PubMed ID: 17628352
    [Abstract] [Full Text] [Related]

  • 11. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec 01; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

  • 12. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG, Pritchett YL, Kajdasz DK, Bauer M, Jain R, Russell JM, Walker DJ, Spencer KA, Froud DM, Raskin J, Thase ME.
    J Psychiatr Res; 2008 Jan 01; 42(1):22-34. PubMed ID: 17445831
    [Abstract] [Full Text] [Related]

  • 13. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec 01; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 14. A randomized double-blind study of carbamazepine in the treatment of cocaine abuse.
    Halikas JA, Crosby RD, Pearson VL, Graves NM.
    Clin Pharmacol Ther; 1997 Jul 01; 62(1):89-105. PubMed ID: 9246023
    [Abstract] [Full Text] [Related]

  • 15. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP.
    Depress Anxiety; 2007 Jul 01; 24(1):41-52. PubMed ID: 16845641
    [Abstract] [Full Text] [Related]

  • 16. Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.
    Elkashef A, Holmes TH, Bloch DA, Shoptaw S, Kampman K, Reid MS, Somoza E, Ciraulo D, Rotrosen J, Leiderman D, Montgomery A, Vocci F.
    Addiction; 2005 Mar 01; 100 Suppl 1():91-101. PubMed ID: 15730353
    [Abstract] [Full Text] [Related]

  • 17. A double-blind trial of low- and high-dose ranges of gepirone-ER compared with placebo in the treatment of depressed outpatients.
    Wilcox CS, Ferguson JM, Dale JL, Heiser JF.
    Psychopharmacol Bull; 1996 Mar 01; 32(3):335-42. PubMed ID: 8961776
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR, Sramek JJ, Keppel Hesselink JM, Krol A, Roeschen J, Rickels K, Schweizer E.
    J Clin Psychopharmacol; 1993 Dec 01; 13(6):429-37. PubMed ID: 7907097
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J.
    Depress Anxiety; 2008 Dec 01; 25(3):182-9. PubMed ID: 17311303
    [Abstract] [Full Text] [Related]

  • 20. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR, Salloum IM, Thase ME, Haskett RF, Daley DC, Jones-Barlock A, Upsher C, Perel JM.
    Psychopharmacol Bull; 1998 Dec 01; 34(1):117-21. PubMed ID: 9564208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.